Literature DB >> 12061909

A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health.

H J Chial1, C Camilleri, S Delgado-Aros, D Burton, G Thomforde, I Ferber, Michael Camilleri.   

Abstract

To assess the effects of age, gender and body mass index on the maximum tolerated volume of a nutrient drink and postprandial symptoms in health. Healthy adolescents (15 M, 15 F, aged 13-17 years) and adults (15 M, 25 F, aged 19-51 years) ingested Ensure (1 kcal mL-1) at a rate of 30 mL min-1. The maximum tolerated volume was recorded. Thirty minutes later, bloating, fullness, nausea and pain were rated using visual analogue scales. The Mann-Whitney test was used for comparisons between groups using body mass index and maximum tolerated volume as covariates. Age-related differences in maximum tolerated volume were noted between adolescents and adults, and were observed in both genders. Adults had higher scores for bloating and pain, and lower scores for fullness. Gender-related differences in maximum tolerated volume were noted in the group as a whole, and separately for adolescents and adults. Females had higher scores for nausea and pain. Gender and age-related differences in the maximum tolerated volume of a nutrient drink and postprandial symptoms should be considered in future studies of upper gastrointestinal symptoms in disease. Body mass index does not appear to influence maximum tolerated volume beyond its association with age and gender.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061909     DOI: 10.1046/j.1365-2982.2002.00326.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  37 in total

1.  Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health.

Authors:  Houssam Halawi; Michael Camilleri; Andres Acosta; Maria Vazquez-Roque; Ibironke Oduyebo; Duane Burton; Irene Busciglio; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

Review 2.  Gastrointestinal traits: individualizing therapy for obesity with drugs and devices.

Authors:  Michael Camilleri; Andres Acosta
Journal:  Gastrointest Endosc       Date:  2015-08-10       Impact factor: 9.427

Review 3.  Satiety testing: ready for the clinic?

Authors:  Michael P Jones
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

4.  Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.

Authors:  Nicholas J Talley; G Richard Locke; Yuri A Saito; Ann E Almazar; Ernest P Bouras; Colin W Howden; Brian E Lacy; John K DiBaise; Charlene M Prather; Bincy P Abraham; Hashem B El-Serag; Paul Moayyedi; Linda M Herrick; Lawrence A Szarka; Michael Camilleri; Frank A Hamilton; Cathy D Schleck; Katherine E Tilkes; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2015-04-25       Impact factor: 22.682

5.  Impact of lap-band size on weight loss: does gender matter?

Authors:  Ali Ardestani; Ardalan Tangestanipoor; Malcolm K Robinson; David B Lautz; Ashley H Vernon; Ali Tavakkoli
Journal:  Obes Surg       Date:  2012-09       Impact factor: 4.129

6.  Association of UCP-3 rs1626521 with obesity and stomach functions in humans.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Maria I Vazquez-Roque; Johanna Iturrino; Ian R Lanza; K Sreekumaran Nair; Duane Burton; Jessica O'Neill; Deborah Eckert; Paula Carlson; Adrian Vella; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2015-03-07       Impact factor: 5.002

7.  Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.

Authors:  Nicholas J Talley; G Richard Locke; Linda M Herrick; Vickie M Silvernail; Charlene M Prather; Brian E Lacy; John K DiBaise; Colin W Howden; Darren M Brenner; Ernest P Bouras; Hashem B El-Serag; Bincy P Abraham; Paul Moayyedi; Alan R Zinsmeister
Journal:  Contemp Clin Trials       Date:  2012-02-10       Impact factor: 2.226

Review 8.  Current management strategies and emerging treatments for functional dyspepsia.

Authors:  Michael Camilleri; Vincenzo Stanghellini
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-05       Impact factor: 46.802

9.  Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Maria I Vazquez-Roque; Johanna Iturrino; Duane Burton; Jessica O'Neill; Deborah Eckert; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2014-12-06       Impact factor: 22.682

10.  Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity.

Authors:  Suwebatu T Odunsi; María I Vázquez-Roque; Michael Camilleri; Athanasios Papathanasopoulos; Matthew M Clark; Lynne Wodrich; Mary Lempke; Sanna McKinzie; Michael Ryks; Duane Burton; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2009-12-03       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.